TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
← New search
Home›Stocks›SSP
SSP logo

SSP

E.W. SCRIPPS Co

Next earnings Aug 5, 2026 · consensus $-0.61 EPS, $532M rev

Last earnings -3.0% on 2026-05-08

Avoid
$3.12
▲ +9.47%
$3.12▲ +48.73%
over 1Y
L $1.54H $5.16
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+9.5%
1W+17.7%
1M-9.3%
3M-14.5%
YTD-21.0%
1Y+48.7%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Avoid
Quality
C-
Valuation
Fair value
Filings
Flagged
Avoid
Conviction
Horizon
Medium (3–12mo)
Street · 9 analysts
Buy

A $275M equity stub sitting on $2.6B of debt in structural decline — the leverage, not the 0.1x sales, is the whole story.

Long-term debt $2.59B · FY2025

Scripps screens optically cheap at 0.1x sales, but that multiple is a mirage created by the capital structure: the $275M equity sits atop $2.59B of long-term debt (plus $8.85M current) against just $27.9M of cash. Netting operating income of $184M with $151M of D&A gives ~$335M of EBITDA, so net leverage is roughly 7.5–8x — and it is rising, not falling. FY2025 operating cash flow collapsed 85.5% to $53.1M, barely enough to service that debt after $46.6M of capex, which is the real reason the equity trades near $3 and the market assigns it almost no value. This is a distressed, thinly-covered balance sheet, not a bargain.

The business underneath is in secular decline dressed up by cyclicality. Revenue fell 14.3% to $2.15B in FY2025 and the company swung to a $101M net loss (diluted EPS -$1.87) with a -8.1% ROE and $577M accumulated deficit. Part of the drop is the odd-year political-advertising trough — 2024's $2.51B benefited from election spend — but the Risk Factors are blunt about the structural problem: 'Linear TV viewing levels have declined in recent years due to cord-cutting and a migration of viewing to streaming,' ad-supported SVOD 'could take advertising dollars from linear TV,' and audience fragmentation threatens both ad rates and the retransmission-consent revenue that props up broadcast economics. A levered, ex-growth advertising business facing commoditized programmatic pricing is precisely the profile that cannot afford 8x leverage.

Is SSP a buy? The one-page verdict, explained →

The options angle

model · matches our verdict
Bear put spread (caution)~60d expiry
  • Long put 3 @ ~0.28 est
  • Short put 3 @ ~0.28 est
debit $0max +$0max $0

AVOID means we wouldn't engage at all — if expressing the short side anyway, only with capped risk.

Open in the calculator →

Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$2.28B$2.45B$2.29B$2.51B$2.15B
Gross profit—————
Operating income$401M$428M-$753M$412M$184M
Net income——-$948M$146M-$101M
Diluted EPS$0.81$1.62-$11.84$1.01-$1.87
Net margin——-41.3%5.8%-4.7%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$2.85B
EV / EBITDA8.5
EV / Sales1.3
EV / FCF437.2
P / FCF43.8
PEG (trailing)—
Earnings yield-35.3%
FCF yield2.3%

Quality & risk

ROIC (est.)3.8%
Free cash flow$6.52M
Total debt$2.59B
Net cash-$2.57B
Piotroski F-Score3/8

Capital returns

Buyback yield0.0%
Dividend yield (est.)5.8%
Shareholder yield5.8%
Shares Δ YoY+2.7%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Recent disclosure tone has skewed negative — read the flagged items.
  1. 8-K Acquisition / disposition2026-05-15

    Closed an asset disposition (Item 2.01); proceeds aid deleveraging of ~$2.6B debt

  2. 8-K Earnings results2026-05-08

    Q1 FY26: soft non-political-year revenue; losses continue to pressure equity

  3. 10-Q Quarterly report2026-05-08

    Q1 FY26: soft non-political-year revenue; losses continue to pressure equity

  4. 8-K Material agreement2026-05-06

    Entered new financing agreement creating direct debt obligation (refinancing)

  5. 8-K Acquisition / disposition2026-04-01

    Completed another asset disposition; continues portfolio pruning to cut debt

  6. DEF 14A Proxy statement2026-03-20

    Annual proxy; routine governance votes, poison-pill rights plan in place

  7. 10-K Annual report2026-02-27

    FY25: revenue -14%, swung to -$101M net loss, EPS -$1.87

  8. 8-K Officer / director change2026-02-26

    FY25 results plus executive/board change amid swing to a net loss

  9. 8-K Reg FD disclosure2026-02-06

    Reg FD investor disclosure/presentation; no financial change

Recent filings

all on EDGAR ↗
4Period ending 2026-05-152026-05-22open ↗4Period ending 2026-05-142026-05-15open ↗8-KPeriod ending 2026-05-152026-05-15open ↗SCHEDULE 13G/AFiling2026-05-14open ↗4Period ending 2026-05-132026-05-14open ↗144Filing2026-05-14open ↗10-QPeriod ending 2026-03-312026-05-08open ↗8-KPeriod ending 2026-05-072026-05-08open ↗8-KPeriod ending 2026-04-302026-05-06open ↗4Period ending 2026-05-042026-05-06open ↗4Period ending 2026-05-042026-05-06open ↗4Period ending 2026-05-042026-05-06open ↗

Quality score

C-
ValueGrowthProfitHealthMom.
ValueA+
GrowthF
ProfitabilityF
Financial healthC
MomentumC+
  • ✗Revenue growing year-over-year
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
1.5452-week5.16
Revenue
$2.15B
-14.3% YoY
Net margin
-4.7%
ROE
-8.1%
P/E
—

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$2.15B-14.3%
Net income-$101M-169.0%
Operating income$184M-55.4%
Diluted EPS-$1.87-285.1%
Cash & equivalents$27.9M+17.1%
Total assets$5.01B-3.7%
Stockholders' equity$1.25B-5.5%
Op.: 8.6%

Frequently asked

Is E.W. SCRIPPS Co (SSP) a buy?
SSP currently carries a Avoid rating with 4/5 conviction, derived from its latest SEC filings. A $275M equity stub sitting on $2.6B of debt in structural decline — the leverage, not the 0.1x sales, is the whole story.
What is E.W. SCRIPPS Co's quality score?
SSP scores 51.252290542604094/100 (grade C-) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0000832428, latest 10-Q filed 2026-05-08) · EODHD · Proprietary analysis · as of 7/3/2026, 10:30:33 AM.

›About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 3, 2026, 6:30 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC

Last 90 days: 2 open-market buys · 4 sales

2026-05-20
McCabe Molly E
10% owner
Sell11.2K @ $3.29$37.0K
2026-05-19
McCabe Molly E
10% owner
Sell112K @ $3.40$382K
2026-05-18
McCabe Molly E
10% owner
Sell143K @ $3.48$497K
2026-05-15
McCabe Molly E
10% owner
Sell60.2K @ $3.35$202K
2026-05-14
Granado Geraldine Scripps
10% owner
Buy72.8K @ $3.54$258K
2026-05-13
Brickner Samantha J.
10% owner
Buy1.26K @ $3.53$4.46K
2026-05-05
Alexander Marcellus Winston Jr
Director
Exercise90.7K
2026-05-05
Barmonde Charles L.
Director
Exercise90.7K
2026-05-05
CONLIN KELLY P
Director
Exercise90.7K
2026-05-05
Granado Raymundo H. Jr.
Director
Exercise90.7K
2026-05-05
HAYDEN JOHN W
Director
Exercise90.7K

Earnings history

beat/miss · move
2026-05-08Beat +61.9% est▼ -22.02%8-K ↗
2026-02-26Miss -13.9% est▲ +11.86%8-K ↗
2025-11-07Miss -46.2% est▲ +5.35%8-K ↗
2025-08-08—▲ +6.05%8-K ↗
2025-07-28—▼ -11.01%8-K ↗
2025-05-09—▲ +4.15%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Congressional trades

all activity →

Disclosed under the STOCK Act

2016-03-03Thomas MacArthurSell$15.0K–$50.0KPTR ↗
2015-09-08Thomas MacArthurBuy$1.00K–$15.0KPTR ↗

Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.

Vs tracked universe

compare →

1195 tracked peers · median

TENK Score51 vs 67
Revenue growth-14.3% vs 7.5%
Net margin-4.7% vs 10.0%
Return on equity-8.1% vs 12.0%
P/E— vs 26.2